← Eichor
Study identifier: NCT07323498 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Enhancing Generalization of Virtual Reality Exposure for Public Speaking Anxiety

Condition: Public Speaking Anxiety · Public Speaking Fear  ·  Sponsor: Philipps University Marburg

PhaseNA
Planned participants48
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This randomized controlled trial examines whether imagery-based extinction memory updating following a standardized virtual reality (VR) exposure session improves the generalization of exposure effects to novel public speaking contexts. Individuals with elevated public speaking anxiety will complete a single-session VR speech exposure. Participants are randomized to (a) standard mental rehearsal of the exposure experience or (b) mental rehearsal plus guided imagery that updates the extinction memory with novel, non-exposed contexts. Generalization is assessed 7-14 days later using a multi-context behavioral approach test (BAT) in vivo and in VR.

This description comes directly from the study's public registry record.

Talk to the study team

Christoph Benke, Ph.D.  ·  +49 6421 28-24091  ·  christoph.benke@uni-marburg.de

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Psychology, Philipps-University of MarburgMarburg, Hesse, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07323498